You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 298 No. 1, July 4, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Neurology
 •Otolaryngology/ Head & Neck Surgery
 •Hearing Loss/ Deafness
 •Neoplasms of Head & Neck
 •Alert me on articles by topic

Mechanisms of Morbid Hearing Loss Associated With Tumors of the Endolymphatic Sac in von Hippel-Lindau Disease

John A. Butman, MD, PhD; H. Jeffrey Kim, MD; Martin Baggenstos, MD; Joshua M. Ammerman, MD; James Dambrosia, PhD; Athos Patsalides, MD; Nicholas J. Patronas, MD; Edward H. Oldfield, MD; Russell R. Lonser, MD

JAMA. 2007;298:41-48.

Context  Endolymphatic sac tumors (ELSTs) are associated with von Hippel-Lindau disease and cause irreversible sensorineural hearing loss (SNHL) and vestibulopathy. The underlying mechanisms of audiovestibular morbidity remain unclear and optimal timing of treatment is not known.

Objective  To define the mechanisms underlying audiovestibular pathophysiology associated with ELSTs.

Design, Setting, and Patients  Prospective and serial evaluation of patients with von Hippel-Lindau disease and ELSTs at the National Institutes of Health between May 1990 and December 2006.

Main Outcome Measures  Clinical findings and audiologic data were correlated with serial magnetic resonance imaging and computed tomography imaging studies to determine mechanisms underlying audiovestibular dysfunction.

Results  Thirty-five patients with von Hippel-Lindau disease and ELSTs in 38 ears (3 bilateral ELSTs) were identified. Tumor invasion of the otic capsule was associated with larger tumors (P = .01) and occurred in 7 ears (18%) causing SNHL (100%). No evidence of otic capsule invasion was present in the remaining 31 ears (82%). SNHL developed in 27 of these 31 ears (87%) either suddenly (14 ears; 52%) or gradually (13 ears; 48%) and 4 ears had normal hearing. Intralabyrinthine hemorrhage was found in 11 of 14 ears with sudden SNHL (79%; P < .001) but occurred in none of the 17 ears with gradual SNHL or normal hearing. Tumor size was not related to SNHL (P = .23) or vestibulopathy (P = .83).

Conclusions  ELST-associated SNHL and vestibulopathy may occur suddenly due to tumor-associated intralabyrinthine hemorrhage, or insidiously, consistent with endolymphatic hydrops. Both of these pathophysiologic mechanisms occur with small tumors that are not associated with otic capsule invasion.


Author Affiliations: Diagnostic Radiology Department, The Clinical Center of the National Institutes of Health (Drs Butman, Patsalides, and Patronas); Neuro-Otology Branch, National Institute on Deafness and Other Communication Disorders, National Institutes of Health (Dr Kim); Surgical Neurology Branch (Drs Baggenstos, Ammerman, Oldfield, and Lonser), Biostatistics Branch (Dr Dambrosia), National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland.


RELATED ARTICLES

Endolymphatic Sac Tumors in von Hippel-Lindau Disease

Arch Otolaryngol Head Neck Surg. ;133():857-857.
FULL TEXT  

Adult Hearing Loss
, , and
JAMA. ;298():130-130.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neurologic Manifestations of von Hippel-Lindau Disease
Butman et al.
JAMA 2008;300:1334-1342.
ABSTRACT | FULL TEXT  

Kidney Diseases: Environmental and Genetic Factors
Grunfeld
CJASN 2008;3:654-657.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.